Top 10 Companies in the Lercanidipine API Market (2025): Key Manufacturers Driving Cardiovascular Therapeutics
The Global Lercanidipine API Market was valued at USD 145.6 Million in 2024 and is projected to reach USD 212.3 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period (2024–2030). This significant growth is propelled by the rising global prevalence of hypertension, increasing demand for cost-effective generic […]
